Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

TAS-114

2 clinical trials

2 indications

Indication
Cancer
Indication
NSCLC
Clinical trial
A Phase I, Open-Label, Non-Randomized, Dose-Escalating Safety, Tolerability and Pharmacokinetic Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors
Status: Completed, Estimated PCD: 2016-12-27
Clinical trial
A Randomized, Open-Label, Multi-Center, International Phase 2 Study of TAS-114 in Combination With S-1 in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Status: Completed, Estimated PCD: 2017-09-30